Arsenic trioxide: acute promyelocytic leukemia and beyond (Q34980350)

5 August 2017

1 reference

title

Arsenic trioxide: acute promyelocytic leukemia and beyond (English)

1 reference

acute promyelocytic leukemia

5 August 2017

1 reference

1 reference

1 reference

based on heuristic

inferred from title

author name string

Bachleitner-Hofmann T

series ordinal

1

1 reference

PubMed ID

12400595

5 August 2017

Kees M

series ordinal

2

1 reference

PubMed ID

12400595

5 August 2017

Gisslinger H

series ordinal

3

1 reference

5 August 2017

1 August 2002

1 reference

5 August 2017

1 reference

5 August 2017

43

1 reference

5 August 2017

8

1 reference

5 August 2017

1535-1540

1 reference

History of the development of arsenic derivatives in cancer therapy

5 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000002857

Clinical experience of arsenic trioxide in relapsed acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000002857

Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000002857

Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000002857

Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000002857

Arsenic induces apoptosis in B-cell leukaemic cell lines in vitro: activation of caspases and down-regulation of Bcl-2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000002857

The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000002857

Arsenic trioxide and ascorbic acid: synergy with potential implications for the treatment of acute myeloid leukaemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000002857

Arsenic trioxide induces apoptosis of HPV16 DNA-immortalized human cervical epithelial cells and selectively inhibits viral gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000002857

Arsenic trioxide inhibits growth of human T-cell leukaemia virus type I infected T-cell lines more effectively than retinoic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000002857

Arsenic trioxide induces apoptosis of myeloid leukemia cells by activation of caspases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000002857

Ascorbic acid enhances arsenic trioxide-induced cytotoxicity in multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000002857

Clinical trials of arsenic trioxide in hematologic and solid tumors: overview of the National Cancer Institute Cooperative Research and Development Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000002857

10.1080/1042819021000002857

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12400595